Baycrest offers clinical trials that study new treatments for dementia. 

We evaluate both drug and non-drug therapies to treat and prevent dementia. Participants should be 50 years old or older.

Why should I join a clinical trial?

• Gain exclusive access to new, emerging treatments 

• Potentially improve or delay your symptoms 

• Contribute to science and the development of future interventions and advances 

How to join a clinical trial

Contact Baycrest’s Clinical Trials Unit

Staff will book an initial health assessment. Note that clinical trials typically require multiple visits to Baycrest. Costs associated with participation can be covered. 

Connect with our staff for a screening appointment

Screening appointments will include: 

• A neurological exam and cognitive screening* 

• Discussion about memory concerns 

• Collection of your medical history 

* Any health findings can be reported to your family doctor. 

Discuss your eligibility for active studies

Each clinical trial has specific criteria for recruitment. Staff can provide details about current studies. 

Book a follow-up appointment

You will be provided details about the clinical trial by the research team. This will include: 

• Expectations and protocol 
• Time commitments 
• Risks and benefits

Individuals or a power of attorney must provide written consent before entering a clinical  trial. All clinical trials must receive approval from the prior to recruitment. 

When you are enrolled in a clinical trial

Your experience with the clinical trial, including any side effects or unexpected health events, should be reported to the study team. Participants may choose to withdraw from a trial at any time.